A project from the American Society of Retina SpecialistsSign in to view content
Evaluating the Visual, Anatomic, and Treatment Effects of Switching from Higher-cost Anti-VEGF to Lower-cost Bevacizumab After Loss of Copay Assistance (Good Days) Funding in Neovascular Age-Related Macular Degeneration
- Video
- Published 2026
Related
Category: Socioeconomics